The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Oral substitution treatment of injecting opioid users for prevention of HIV infection
Open accessAbstract
BACKGROUND: Injecting drug users are vulnerable to infection with Human Immunodeficiency Virus (HIV) and other blood borne viruses as a result of collective use of injecting equipment as well as sexual behaviour OBJECTIVES: To assess the effect of oral substitution treatment for opioid dependent injecting drug users on risk behaviours and rates of HIV infections SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and PsycINFO to May 2011. We also searched reference lists of articles, reviews and conference abstracts SELECTION CRITERIA: Studies were required to consider the incidence of risk behaviours, or the incidence of HIV infection related to substitution treatment of opioid dependence. All types of original studies were considered. Two authors independently assessed each study for inclusion DATA COLLECTION AND ANALYSIS: Two authors independently extracted key information from each of the included studies. Any differences were resolved by discussion or by referral to a third author. MAIN RESULTS: Thirty-eight studies, involving some 12,400 participants, were included. The majority were descriptive studies, or randomisation processes did not relate to the data extracted, and most studies were judged to be at high risk of bias. Studies consistently show that oral substitution treatment for opioid-dependent injecting drug users with methadone or buprenorphine is associated with statistically significant reductions in illicit opioid use, injecting use and sharing of injecting equipment. It is also associated with reductions in the proportion of injecting drug users reporting multiple sex partners or exchanges of sex for drugs or money, but has little effect on condom use. It appears that the reductions in risk behaviours related to drug use do translate into reductions in cases of HIV infection. However, because of the high risk of bias and variability in several aspects of the studies, combined totals were not calculated. AUTHORS' CONCLUSIONS: Oral substitution treatment for injecting opioid users reduces drug-related behaviours with a high risk of HIV transmission, but has less effect on sex-related risk behaviours. The lack of data from randomised controlled studies limits the strength of the evidence presented in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61311-2 · Cited by 1,285
Self-report among injecting drug users: A review
Darke, S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00028-3 · Cited by 1,141
Substance Abuse: A Comprehensive Textbook
Krueger, A. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500040103051 · Cited by 870
The Effectiveness of Methadone Maintenance Treatment
Ball, J. C., & Ross, A. (1991) · Springer eBooks · doi:10.1007/978-1-4613-9089-3 · Cited by 590
Fudala, P. J., Bridge, T. P., Herbert, S., Williford, W. O., Chiang, C. N., Jones, K., Collins, J., Raisch, D., Casadonte, P., Goldsmith, R. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022164 · Cited by 577
Marsch, L. A. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9345157.x · Cited by 553
Metzger, D. S., WOODY, G. E., McLellan, A. T., O’Brien, C. P., Druley, P., Navaline, H. A., DePhilippis, D., Stolley, P. D., & Abrutyn, E. (1993) · PubMed · Cited by 530
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users
Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., Feiner, C., & Friedland, G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909283211306 · Cited by 494
Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., Banys, P., & Hall, S. M. (2000) · JAMA · doi:10.1001/jama.283.10.1303 · Cited by 415
Methadone maintenance at different dosages for opioid dependence
Faggiano, F., Vigna-Taglianti, F., Versino, E., & Lemma, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002208 · Cited by 406
Reducing the Risk of AIDS Through Methadone Maintenance Treatment
Ball, J. C., Lange, W. R., Myers, C. P., & Friedman, S. R. (1988) · Journal of Health and Social Behavior · doi:10.2307/2137033 · Cited by 405
The National Treatment Outcome Research Study (NTORS): 4–5 year follow‐up results
Gossop, M., Marsden, J., Stewart, D., & Kidd, T. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00296.x · Cited by 401
Woody, G. E., Poole, S. A., Subramaniam, G., Dugosh, K., Bogenschutz, M., Abbott, P., Patkar, A., Publicker, M., McCain, K., Potter, J. S., et al. (2008) · JAMA · doi:10.1001/jama.2008.574 · Cited by 361
Counseling plus Buprenorphine–Naloxone Maintenance Therapy for Opioid Dependence
Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055255 · Cited by 351
Self-citationStrathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., & Nelson, K. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.10.1281 · Cited by 331
Methadone Maintenance Treatment and other Opioid Replacement Therapies
Hall, J. W. P. M. (1997) · Cited by 316
Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02269.x · Cited by 283
KREEK, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06683.x · Cited by 258
Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J., & Wodak, A. D. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01050.x · Cited by 243
Lawrinson, P., Ali, R., Buavirat, A., Chiamwongpaet, S., Dvoryak, S., Habrat, B., Jie, S., Mardiati, R., Mokri, A., Moskalewicz, J., et al. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02249.x · Cited by 237
Self-citationStimson, G. V. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(94)00435-v · Cited by 230
Client engagement and change during drug abuse treatment
Simpson, D. D., Joe, G. W., Rowan-Szal, G., & Greener, J. (1995) · Journal of Substance Abuse · doi:10.1016/0899-3289(95)90309-7 · Cited by 226
Dolan, K. A., Shearer, J., MacDonald, M., Mattick, R. P., Hall, W., & Wodak, A. D. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00187-x · Cited by 203
HIV seroconversion in intravenous drug users in San Francisco, 1985–1990
Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D. (1994) · AIDS · doi:10.1097/00002030-199402000-00010 · Cited by 178
Shah, N. G., Galai, N., Celentano, D. D., Vlahov, D., & Strathdee, S. A. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.007 · Cited by 174
Margolin, A., Avants, S. K., Warburton, L. A., Hawkins, K. A., & Shi, J. (2003) · Health Psychology · doi:10.1037//0278-6133.22.2.223 · Cited by 173
Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection
O'Connor, P. G., Selwyn, P. A., & Schottenfeld, R. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310707 · Cited by 165
A Randomized Controlled Trial of Interim Methadone Maintenance
Schwartz, R. P., Highfield, D. A., Jaffe, J. H., Brady, J. V., Butler, C. B., Rouse, C. O., Callaman, J. M., O’Grady, K. E., & Battjes, R. J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.102 · Cited by 162
Gender Differences at Admission and Follow-up in a Sample of Methadone Maintenance Clients
Chatham, L. R., Hiller, M. L., Rowan‐Szal, G. A., Joe, G. W., & Simpson, D. D. (1999) · Substance Use & Misuse · doi:10.3109/10826089909039401 · Cited by 157
Antisocial personality disorder and HIV infection among intravenous drug abusers
Brooner, R. K., Greenfield, L., Schmidt, C. W., & Bigelow, G. E. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.1.53 · Cited by 152
Effectiveness of first eight methadone maintenance treatment clinics in China
Pang, L., Hao, Y., Mi, G., Wang, C., Luo, W., Rou, K., Li, J., & Wu, Z. (2007) · AIDS · doi:10.1097/01.aids.0000304704.71917.64 · Cited by 151
Teesson, M., Ross, J., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.009 · Cited by 141
Self-citationGrund, J., Friedman, S. R., Stern, L. S., Jose, B., Neaigus, A., Curtis, R., & Jarlais, D. C. D. (1996) · Social Science & Medicine · doi:10.1016/0277-9536(95)00193-x · Cited by 138
Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy
Parran, T. V., Adelman, C., Merkin, B., Pagano, M. E., Defranco, R., Ionescu, R. A., & Mace, A. G. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.07.013 · Cited by 130
Retention, HIV risk, and illicit drug use during treatment: methadone dose and visit frequency.
Rhoades, H. M., Creson, D. L., Elk, R., Schmitz, J. M., & Grabowski, J. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.34 · Cited by 129
Gossop, M., Marsden, J., Stewart, D., & Rolfe, A. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00109-5 · Cited by 126
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)
Spire, B., Lucas, G. M., & Carrieri, P. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.12.014 · Cited by 125
Lucas, G. M., Chaudhry, A. A., Hsu, J., Woodson, T., Lau, B. M., Olsen, Y. K., Keruly, J. C., Fiellin, D. A., Finkelstein, R., Barditch‐Crovo, P., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00003 · Cited by 119
Hartel, D. M., & Schoenbaum, E. E. (1998) · PubMed · Cited by 116
Methadone Maintenance and the Likelihood of Risky Needle-Sharing
Caplehorn, J. R. M., & Ross, M. W. (1995) · International Journal of the Addictions · doi:10.3109/10826089509048753 · Cited by 111
Gossop, M., Marsden, J., Stewart, D., Lehmann, P., & Strang, J. (1999) · PubMed Central · Cited by 110
Avants, S. K., Margolin, A., Sindelar, J. L., Rounsaville, B. J., Schottenfeld, R., Stine, S., Cooney, N. L., Rosenheck, R. A., Li, S.-H., & Kosten, T. R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.27 · Cited by 108
Avants, S. K., Margolin, A., Usubiaga, M. H., & Doebrick, C. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00159-4 · Cited by 106
Drug abuse treatment success among needle exchange participants.
Brooner, R. K., KIDORF, M. S., King, V. L., Beilenson, P. L., Svikis, D. S., & Vlahov, D. (1998) · PubMed Central · Cited by 104
Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.
Selwyn, P. A., Feiner, C., Cp, C., et al. (1987) · PubMed · Cited by 102
Sullivan, L. E., Moore, B. A., Chawarski, M. C., Pantalon, M. V., Barry, D. T., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.08.004 · Cited by 101
Self-citationSchottenfeld, R. S., Chawarski, M. C., & Mazlan, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60954-x · Cited by 99
Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area
Thiede, H., Hagan, H., & Murrill, C. S. (2000) · Journal of Urban Health · doi:10.1007/bf02386744 · Cited by 87
Methadone maintenance treatment reduces heroin injection in New South Wales prisons
Dolan, K. A., WODAK, A. D., & Hall, W. (1998) · Drug and Alcohol Review · doi:10.1080/09595239800186951 · Cited by 87
Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy
Gill, K., Nolimal, D., & Crowley, T. J. (1992) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(92)90059-l · Cited by 85
Marsch, L. A., Bickel, W. K., Badger, G. J., & Jacobs, E. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.08.011 · Cited by 84
Camacho, L. M., Bartholomew, N. G., Joe, G. W., Cloud, M. A., & Simpson, D. D. (1996) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(96)01235-5 · Cited by 83
Community Reinforcement Approach in the Treatment of Opiate Addicts
Abbott, P. J., Weller, S. B., Delaney, H. D., & Moore, B. A. (1998) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999809001696 · Cited by 81
HIV infection and cocaine use in methadone maintained and untreated intravenous drug users
Meandzija, B., O’Connor, P. G., Fitzgerald, B. J., Rounsaville, B. J., & Kosten, T. R. (1994) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(94)90092-2 · Cited by 79
Gossop, M., Marsden, J., Stewart, D., & Treacy, S. (2002) · AIDS Care · doi:10.1080/09540120220097955 · Cited by 78
Predictors of Opiate Drug Abuse during a 90-Day Methadone Detoxification
Iguchi, M. Y., & Stitzer, M. L. (1991) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999109027552 · Cited by 78
The effect of methadone maintenance on positive outcomes for opiate injection drug users
Corsi, K. F., Lehman, W., & Booth, R. E. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2008.11.004 · Cited by 78
Miller, C. L., Kerr, T. H., Frankish, J., Spittal, P. M., Li, K. K., Schechter, M. T., & Wood, E. (2006) · Substance Use & Misuse · doi:10.1080/10826080500391795 · Cited by 77
Incarceration and drug use patterns among a cohort of injection drug users
DeBeck, K., Kerr, T. H., Li, K. K., Milloy, M., Montaner, J. S. G., & Wood, E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02387.x · Cited by 75
Watkins, K. E., Metzger, B. A. D., WOODY, G. E., & McLellan, A. T. (1992) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999209051037 · Cited by 73
Influence of Psychiatric Comorbidity on HIV Risk Behaviors: Changes During Drug Abuse Treatment
King, V. L., KIDORF, M. S., Stoller, K. B., & Brooner, R. K. (2000) · Journal of Addictive Diseases · doi:10.1300/j069v19n04_07 · Cited by 69
Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia
Darke, S. G., Hall, W., & Carless, J. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb01649.x · Cited by 68
A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care
Sullivan, L. E., Barry, D. T., Moore, B. A., Chawarski, M. C., Tetrault, J. M., Pantalon, M. V., O’Connor, P. G., Schottenfeld, R. S., & Fiellin, D. A. (2006) · Clinical Infectious Diseases · doi:10.1086/508182 · Cited by 68
Self-citationMcCusker, J., Bigelow, C., Luippold, R. S., Zorn, M., & Lewis, B. F. (1995) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999509095225 · Cited by 67
Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.
Chitwood, D. D., Griffin, D. K., Comerford, M., Page, J. B., Trapido, E. J., Lai, S., & McCoy, C. B. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.11.1538 · Cited by 67
Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency
Epstein, D. H., Schmittner, J. P., Umbricht, A., Schroeder, J. R., Moolchan, E. T., & Preston, K. L. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.006 · Cited by 66
Roux, P., Villes, V., Blanche, J., Bry, D., Spire, B., Feroni, I., & Carrieri, P. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.025 · Cited by 66
Serpelloni, G., Carrieri, P., Rezza, G., Morganti, S., Gomma, M., & BINKIN, N. J. (1994) · AIDS Care · doi:10.1080/09540129408258632 · Cited by 66
Methadone Maintenance and Needle/Syringe Sharing
Longshore, D. L., Hsieh, S., Danila, B., & Anglin, M. D. (1993) · International Journal of the Addictions · doi:10.3109/10826089309062178 · Cited by 66
Millson, P. E., Challacombe, L., Villeneuve, P. J., Strıke, C., Fischer, B., Myers, T., Shore, R., & Hopkins, S. (2007) · AIDS Education and Prevention · doi:10.1521/aeap.2007.19.2.124 · Cited by 66
Schroeder, J., Epstein, D., Umbricht, A., & Preston, K. (2006) · Addictive Behaviours · doi:10.1016/j.addbeh.2005.07.009 · Cited by 63
Vanichseni, S., Wongsuwan, B., Choopanya, K., & Wongpanich, K. (1991) · International Journal of the Addictions · doi:10.3109/10826089109062163 · Cited by 62
Methadone Maintenance as HIV Risk Reduction With Street-Recruited Injecting Drug Users
Kwiatkowski, C. F., & Booth, R. E. (2001) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200104150-00014 · Cited by 60
Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users
Wong, K.-H., Lee, S. S., Lim, W.-L., & Low, H.-K. (2003) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(03)00029-1 · Cited by 58
Interim methadone treatment: Impact on arrests
Schwartz, R. P., Jaffe, J. H., O’Grady, K. E., Kinlock, T. W., Gordon, M., Kelly, S. M., Wilson, M. E., & Ahmed, A. U. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.007 · Cited by 56
Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users
Williams, A. B., McNelly, E. A., WILLIAMS, A. E., & D’Aquila, R. T. (1992) · AIDS Care · doi:10.1080/09540129208251618 · Cited by 54
Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors
Greenfield, L., Bigelow, G. E., & Brooner, R. K. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01155-r · Cited by 53
Methadone maintenance in prison: Evaluation of a pilot program in Puerto Rico
Heimer, R., Catania, H., Newman, R. G., Zambrano, J. A., Brunet, A., & Ortiz, A. M. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.11.004 · Cited by 51
Ball, J. C., Corty, E. W., Bond, H., Myers, C. P., & Tommasello, A. (1988) · PsycEXTRA Dataset · doi:10.1037/e469072004-001 · Cited by 49
Baker, A., KOCHAN, N., Dixon, J. E., WODAK, A. D., & Heather, N. (2003) · Addiction · doi:10.1046/j.1360-0443.1995.9045458.x · Cited by 47
Changes in Cocaine Use After Entry to Methadone Treatment
Magura, S., Siddiqi, Q., Freeman, R. C., & Lipton, D. S. (1991) · Journal of Addictive Diseases · doi:10.1300/j069v10n04_03 · Cited by 47
Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up
Camacho, L. M., Bartholomew, N. G., Joe, G. W., & Simpson, D. D. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00056-2 · Cited by 47
Wells, E. A., Calsyn, D. A., Clark, L. L., et al. (1996) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999609001677 · Cited by 46
Steffen, T. (2001) · European Journal of Public Health · doi:10.1093/eurpub/11.4.425 · Cited by 45
Charnaud, B., & Griffiths, V. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00052-0 · Cited by 43
Changes in HIV Risk Behaviors Among Cocaine-Using Methadone Patients
Magura, S., Rosenblum, A., & Rodriguez, E. M. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n04_07 · Cited by 41
Lott, D. C., Strain, E. C., Brooner, R. K., Bigelow, G. E., & Johnson, R. E. (2006) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.04.005 · Cited by 40
Behavioural change in injecting drug users: Evaluation of an HIV/AIDS education programme
Martin, G., Serpelloni, G., Galvan, U., Rizzetto, A., Gomma, M., Morgante, S., & Rezza, G. (1990) · AIDS Care · doi:10.1080/09540129008257740 · Cited by 39
Longshore, D. L., Hsieh, S., & Anglin, M. D. (1994) · International Journal of the Addictions · doi:10.3109/10826089409047907 · Cited by 39
Sex, Drugs, and HIV: Does Methadone Maintenance Reduce Drug Use and Risky Sexual Behavior?
Lollis, C. M., Strothers, H., Chitwood, D. D., et al. (2000) · Journal of Behavioral Medicine · doi:10.1023/a:1005555519831 · Cited by 38
Longitudinal changes in injection behaviors in a cohort of injection drug users
Saxon, A. J., Calsyn, D. A., & JACKSON, T. R. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb00878.x · Cited by 38
Chawarski, M. C., Mazlan, M., & Schottenfeld, R. S. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.008 · Cited by 38
HIV Risk Reduction in Outpatient Drug Abuse Treatment: Individual and Geographic Differences
Broome, K. M., Joe, G. W., & Simpson, D. D. (1999) · AIDS Education and Prevention · doi:10.1521/aeap.1999.11.4.293 · Cited by 37
Baker, A., KOCHAN, N., Dixon, J. E., WODAK, A. D., & Heather, N. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb02189.x · Cited by 37
Drug injection cessation among HIV-infected injecting drug users
Bouhnik, A., Carrieri, P., Rey, D., Spire, B., Gastaut, J., Gallais, H., & Obadia, Y. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.01.006 · Cited by 36
Patients Successfully Maintained With Methadone Escaped Human Immunodeficiency Virus Infection
Barthwell, A. G. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810100099020 · Cited by 36
Impact of methadone on drug use and risky sex in China
Qian, H., Hao, C., Ruan, Y., Cassell, H. M., Chen, K., Qin, G., Yin, L., Schumacher, J. E., Liang, S., & Shao, Y. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.07.002 · Cited by 35
Shi, J., Zhao, L., Epstein, D., Zhao, C.-Z., Shuai, Y., Yan, B., Jin, J., & Lu, L. (2007) · Journal of addiction medicine · doi:10.1097/adm.0b013e318156cc19 · Cited by 35
Fischer, B., Gliksman, L., Rehm, J. T., Daniel, N., & Medved, W. (1999) · Canadian Journal of Public Health · doi:10.1007/bf03404513 · Cited by 33
Participation in an Outreach-Based Coupon Distribution Program for Free Methadone Detoxification
Bux, D. A., Iguchi, M. Y., Lidz, V., Baxter, R. C., & Platt, J. J. (1993) · Psychiatric Services · doi:10.1176/ps.44.11.1066 · Cited by 33
Tunis, S. L., Delucchi, K., Schwartz, K., Banys, P., & Sees, K. L. (1995) · Addictive Behaviors · doi:10.1016/0306-4603(94)00080-i · Cited by 33
Reduction or cessation of injecting risk behaviours? Treatment outcomes at 1-year follow-up
Gossop, M., Marsden, J., Stewart, D., & Kidd, T. (2003) · Addictive Behaviors · doi:10.1016/s0306-4603(01)00279-9 · Cited by 32
Meade, C. S., Weiss, R. D., Fitzmaurice, G. M., Poole, S. A., Subramaniam, G., Patkar, A. A., Connery, H. S., & WOODY, G. E. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181d916db · Cited by 31
Abbott, P. J., Moore, B. A., Weller, S. B., & Delaney, H. D. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n04_04 · Cited by 30
Suntharasamai, P., Martin, M., Vanichseni, S., van Griensven, F., Mock, P. A., Pitisuttithum, P., Tappero, J. W., Sangkum, U., Kitayaporn, D., Gurwith, M., et al. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02436.x · Cited by 30
Avants, S. K., Margolin, A., Kosten, T. R., Rounsaville, B. J., & Schottenfeld, R. S. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.66.6.924 · Cited by 30
[Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima, A., Henrion, R., Lowenstein, W., & Charpak, Y. (2001) · PubMed · Cited by 30
Anglin, M. D., Conner, B. T., Annon, J., & Longshore, D. L. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01935.x · Cited by 29
Corsi, K. F., Kwiatkowski, C. F., & Booth, R. E. (2002) · Journal of Drug Issues · doi:10.1177/002204260203200316 · Cited by 28
Schaub, M. P., Subata, E., Chtenguelov, V., Weiler, G., & Uchtenhagen, A. (2009) · European Addiction Research · doi:10.1159/000217586 · Cited by 24
Short-term Outcomes for the Treatment of Heroin Dependence
Ross, J. E., Teesson, M., Darke, S. G., Lynskey, M. T., Ali, R. L., Ritter, A. J., & Cooke, R. (2006) · Addictive Disorders & Their Treatment · doi:10.1097/01.adt.0000210717.33564.a8 · Cited by 23
Self-citationSteffen, T., Christen, S., Blättler, R., & Gutzwiller, F. (2001) · Substance Use & Misuse · doi:10.1081/ja-100000229 · Cited by 23
Hartel, D. M., Schoenbaum, E. E., Selwyn, P. A., FRIEDLAND, G. H., Klein, R. S., & Drucker, E. (1996) · Addiction Research & Theory · doi:10.3109/16066359609005246 · Cited by 22
Factors Associated with Client-Reported HIV Infection Among Clients Entering Methadone Treatment
MacGowan, R. J., Fichtner, R. R., Swanson, N., Collier, C., Kroliczak, A., & Cole, G. E. (1997) · AIDS Education and Prevention · doi:10.1521/aeap.1997.9.3.205 · Cited by 20
Barry, D., Weinstock, J., & Petry, N. M. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.009 · Cited by 17
Retrospective Analyses of Additional Services for Methadone Maintenance Patients
Abbott, P. J., Moore, B. A., Delaney, H., & Weller, S. B. (1999) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(98)00068-3 · Cited by 17
Changing needle practices in community outreach and methadone treatment
Wechsberg, W. M., Cavanaugh, E. R., Dunteman, G. H., & Smith, F. J. (1994) · Evaluation and Program Planning · doi:10.1016/0149-7189(94)90037-x · Cited by 17
Peters, A. D., & Reid, M. M. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)00161-0 · Cited by 17
Batki, S. L., Sorensen, J. L., Gibson, D. R., & Maude‐Griffin, P. M. (1989) · PsycEXTRA Dataset · doi:10.1037/e468432004-001 · Cited by 16
Mark, H., Nanda, J. P., Davis-Vogel, A., Navaline, H. A., Scotti, R., Wickrema, R., Metzger, D. S., & Sochalski, J. A. (2006) · Public Health Nursing · doi:10.1111/j.0737-1209.2006.230103.x · Cited by 15
A Low Threshold Methadone Stabilisation Programme–Description and First Stage Evaluation
Finch, E., Groves, I., Feinmann, C., & Farmer, R. (1995) · Addiction Research & Theory · doi:10.3109/16066359509005223 · Cited by 15
Rosenbach, A., & Hunot, V. (2003) · Addiction · doi:10.1046/j.1360-0443.1995.9068159.x · Cited by 13
Reduced Infections With HIV and Hepatitis A During a Swiss Intravenous Opiate Maintenance Program
Naef, M., Bucher, H. C., Erb, P., Gyr, N. E., Bassetti, S., & Battegay, M. (1999) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-199908010-00016 · Cited by 13
Methadone maintenance treatment: outcomes from the Otago methadone programme.
Dore, G. M., Walker, J. D., Paice, J. R., & Clarkson, S. (1999) · PubMed · Cited by 12
Rosenbach, A., & Hunot, V. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb02230.x · Cited by 10
Gallagher, T. J., Cottler, L. B., Compton, W. M., & Spitznagel, E. L. (1997) · Journal of Drug Issues · doi:10.1177/002204269702700213 · Cited by 8
Longitudinal Effects of LAAM and Methadone Maintenance on Heroin Addict Behavior
Anglin, M. D., Conner, B. T., Annon, J. J., & Longshore, D. L. (2008) · The Journal of Behavioral Health Services & Research · doi:10.1007/s11414-008-9155-x · Cited by 7
Risk Dimensions of HIV-Tested Substance Users
Ottomanelli, G. A. (1993) · International Journal of the Addictions · doi:10.3109/10826089309062195 · Cited by 5
Cited by
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572
D’Onofrio, G., O’Connor, P. G., Pantalon, M. V., Chawarski, M. C., Busch, S. H., Owens, P. H., Bernstein, S. L., & Fiellin, D. A. (2015) · JAMA · doi:10.1001/jama.2015.3474 · Cited by 910
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
Connery, H. S. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000075 · Cited by 576
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
Metadata
- Authors
- Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2011-08-10
- Volume
- 2011
- Issue
- 8
- Pages
- CD004145-CD004145
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1971540772
- Cited by
- 296
- References
- 131
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.